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Surprisingly little is known about the actual process of how firms engage in accessing and 
translating science-driven basic knowledge and turning this into improved applied research 
productivity.  We  study  this  process  focused  around  a  research  corporation  in  the 
microelectronics and semiconductor industry. We show that firms which have a partnership 
with the research  organization  where  at  the  same  time  inventors  cross  from  the  research 
organization into the firm develop higher quality technologies drawing on the basic research 
knowledge from the research organization. These same firms also spend more effort internally 
developing these initial technologies into more applied technologies capturing more value 
from these interactions with science-driven basic knowledge. 
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1.  Introduction 
An important and recurrent concern in economics and management has been to understand to 
what  extent  basic  research  influences  technological  progress  and,  ultimately,  economic 
growth. More recent evidence suggests that industrial firms are intensifying their links to 
basic  research  performed  by  universities  and  other  research  organizations  (Cassiman, 
Veugelers  and  Van  Looy,  INNOS&T).  In  spite  of  these  growing  connections  our 
understanding at the micro-level of the variety and distribution of these links and how they 
affect industrial innovation remains unclear. Moreover, concern has been mounting about a 
widening  gap  between science-driven  basic research  and  problem-driven  applied  research 
leading to what in the biomedical sciences has been dubbed “the valley of death” with a lot of 
investment in biomedical science leading to few additional lives saved (Butler, 2008). 
In this paper we carefully examine the links to a research organization performing 
science-driven basic research and how such links  can have an impact on   firms’ applied 
research productivity. We contribute to the literature in several ways. First, we move the 
analysis to a more disaggregate level.   Firms that actively link with basic research will have a 
portfolio of innovative projects. It is important to examine the effect of the links to basic 
research on the projects exploiting such links and compare them to similar projects of firms 
without such links.  Second, we examine the effect of different links to basic research.  Next 
to  the  decision  of  joining  a  cooperative  basic  research  program,  we  also  look  at  the 
importance  of  boundary  crossing  inventors,  i.e.  inventors  that  move  between  basic  and 
applied research organizations .  Third, we examine different ways  through which  firms 
might capture returns from linking to basic research: the value and quality of technologies 
developed based on basic research and the success of firms in developing these more basic 
technologies further into more applied technologies. Together the combination of different 
links and different measures of capturing value from basic research provide us with a first 
glimpse into the process of the transfer of basic research into applied technology development.  
The links to basic research that we examine are the links through IMEC, a world class 
research  organization  performing  basic  research  in  micro-electronics  and  semiconductors. 
IMEC has the expressed objective to bridge the gap between fundamental research done at 
universities and applied R&D in the industry. By financially contributing, firms can become 
an  IMEC  partner,  i.e.  buy  “a  seat  at  the  table”.  As  a  result,  they  gain  access  to  IMEC 
developed  proprietary  basic  technologies.  In  addition,  IMEC  runs  an  industrial  affiliates 
program where partner firms can sign up to specific research programs in their area of interest. 
By sending researchers to participate in the basic research program at IMEC where they 
interact with researchers of IMEC and other partners involved in the program, partners can   3 
acquire “a spot in the lab”.
1 IMEC negotiates an elaborate IP agreement with its partners.  
This allows us to track through patent information the effects of affiliation to IMEC as well as 
the actual mobility of people and ideas.  
The analysis involves comparing patents with different treatments of links to basic 
research developed at the research organization. Patents of firms that are IMEC partners are 
compared  to  patents  of  non-partnering  firms.  This  allows  us  to  trace  the  effect  of 
organizational affiliation to the research center. In addition, we compare patents of boundary 
crossing inventors that have been participating in basic research programs at the research 
organization versus patents of inventors who did not participate in such a program.  This 
allows us to trace the effect of cross-institutional mobility of researchers.  We do this for both 
partnering and non-partnering firms to examine any differential effect from using an inventor 
link  between  partners  and  non-partners,  as  the  latter  can  also  poach  inventors  who  have 
visited IMEC to obtain access to the basic research knowledge.  This allows us to trace any 
complementarity effect from combining both types of links. 
We find that firms linked to basic research through an IMEC partnership and who use 
boundary crossing inventors are more likely to develop higher quality innovations. Partner 
firms continue to build internally on these technologies, improving appropriation of returns 
from follow-up innovations. Interestingly, inventor mobility is an important link, but only 
when used in combination with affiliation to IMEC.  Poaching of IMEC inventors by firms 
without an organizational link to IMEC is a less successful strategy.  This complementarity 
between having a partnership and using boundary crossing inventors is particularly important 
for further developing applied technologies based on this basic knowledge. 
While our findings are derived from the analysis of the interaction with a particular 
research organization in microelectronics and semiconductors, we believe that our findings 
have more general appeal. First, we argue that the effects of basic research on outcomes need 
to be analyzed on a subset of technologies of the firms, through a series  links and on a 
selection of outcomes. Otherwise, it will be difficult to pin-point any tangible effects of these 
interactions with science-driven basic knowledge. Second, connecting to science-based basic 
research  will  typically  require  the  crossing  of  boundaries  of  research  communities  and 
institutions.  Tracing  these  benefits  will  involve  setting  up  partnerships  and  organizing 
interactions  at  the  researcher  level.  The  advantage  of  strong  coordination  in  the 
microelectronics  and  semiconductors  in  particular  fields  eases  the  empirical  design  for 
examining  these  effects.  The  coordination  between  different  players  in  the  industry 
(equipment suppliers, semiconductor firms, application developers) might be less of an issue 
in  for  example  the  pharmaceutical  industry,  but  some  form  of  communication  between 
                                                 
1 We thank Rosemary Ziedonis for suggesting this use of language.   4 
different  research  communities  will  be  necessary  in  order to  capture  value from  science-
driven basic knowledge.  
In  the  following  section  we  discuss  the  gaps  in  the  literature  and  develop  some 
empirical predictions related to the process of how firms effectively appropriate returns for 
their innovation process through linking to science-driven basic research.  Section 3 discusses 
the empirical setting of IMEC. Section 4 elaborates on our data development and methods 
while Section 5 presents our results. Section 6 concludes with some caveats and directions for 
further research. 
 
2.  Bridging the Gap 
Criteria for judging a new scientific contribution differ from the criteria for evaluating a new 
technological development. For this reason science-driven basic research and applied research 
are typically developed in distinct institutional settings, which complicates the development 
of basic research inside firms (Gittelman and Kogut, 2003). Aghion et al (2009) show that 
universities have more incentive to engage in early stage science-driven basic research. Closer 
to commercialization firms are willing to step in and take over the projects as they have an 
incentive  to  direct  this  research  towards  completion.  Lacetera  (2009)  argues  that  by 
outsourcing R&D projects to universities, firms provide a credible commitment not to abort 
or alter projects with a more basic character and less certain commercial outcomes.  These 
projects are of intrinsic value to university researchers responsive to the incentives defined by 
their community of peers. As a result, a gap between applied technology development at firms 
and more basic research in other organizations needs to be bridged before basic research can 
be translated and developed into new applied technologies. 
Bridging these institutional barriers? is not trivial.  This is particularly the case as 
tacit knowledge plays an important role in the basic research environment.  Bessen (2011) 
argues that the tacitness of knowledge is endogenous. Organizations will only cover the cost 
of codifying knowledge whenever the benefit is sufficiently high. Hence, we should expect 
basic research knowledge to be less codified as it is harder to appropriate returns to this 
knowledge. 
As a consequence of the existence of this organizational gap between science-driven 
basic  research  and  problem-driven  applied  research  and  the  tacitness  of  the  knowledge 
involved, crossing organizational boundaries seems an important requirement  for firms to 
access  basic  research  knowledge  with  an  important  scientific  content.  Non-codified 
knowledge impedes the use of contracts as mechanism to transfer non-codified knowledge 
between organizations. Other transfer mechanisms of the embodied kind are more appropriate, 
involving  inventors  with  a  scientific  profile  as  bridge  between  these  two  environments. 
Zucker & Darby (2001) for instance, find star-scientists in bio- and nano-technology to travel   5 
with their knowledge in order to assure the correct translation and development of the basic 
research knowledge into new products and processesPublic policies around the globe promote 
active collaboration and personnel exchange between universities and industry, such as the 
NSF Grant Opportunities for Academic Liaison with Industry program in the US (Dietz and 
Bozeman, 2005). However, little empirical work has explicitly examined who these boundary 
crossing  researchers  are  and  how  they  can  effectively  bridge  scientific  and  technology 
communities (Allen, 1977, Tushman & Scanlon 1981, Dietz and Bozeman, 2005, Breschi and 
Catalini, 2010). 
 
2.1   How to bridge the Gap? 
The  literature  has  highlighted  two  modes  to  transfer  knowledge  across  organizational 
boundaries: firm level connections and “mobility” of individual researchers. 
At the firm-level, the most widely studied mechanism is partnerships between firms 
and  universities  or  other  multidisciplinary  research  organizations.  The  pre-eminence  of 
cooperative  agreements  as  a  mechanism  to  access  basic  research  is  reminiscent  of  the 
importance of crossing institutional boundaries for effective knowledge transfers (Kogut and 
Zander, 1992; Rosenkopf and Nerkar, 2001). This holds in particular for more tacit science-
based technologies (Gittleman and Kogut, 2003; Bessen, 2011).  To study the effect of such 
cooperative  agreements  on  firm  performance,  the  largest  set  of  empirical  papers  uses  a 
(knowledge) production function approach (e.g. Audretsch and Stephan, 1996; Zucker et al 
1998; Cockburn and Henderson, 1998; Brandstetter and Sakakibara, 1998). The empirical 
evidence  from  these  studies  find  a  positive  effect  from  cooperation  with  universities  and 
public research organizations on innovation productivity and  innovative sales, at least for 
firms with own R&D capacity (Belderbos et al, 2004; Belderbos et al, 2006).  This latter 
result supports the complementarity between cooperation with these research organizations 
and internal R&D. Beyond partnerships with research institutes, also ties with academic star 
scientists, either through co-publications or board positions, are, especially in biotech, found 
to lead to more patenting (Henderson and Cockburn, 1996; Zucker et al, 2002; Cockburn and 
Henderson,  1998);  more  “important”  patents:  i.e.  international  patents  (Henderson  and 
Cockburn, 1994); and a higher average of quality adjusted patenting (Zucker and Darby, 2001; 
Zucker et al, 2002).   
At the inventor level, those inventors co-publishing with universities are found to 
generate  patents  that  exploit  more  prominently  (citations  to)  science,  confirming  their 
boundary spanning role.   These inventors also produce patents with shorter lags between 
existing inventions and new firm inventions in the pharmaceutical industry (Fabrizio, 2009). 
The involvement of an academic inventor in the invention team is found to lead to more 
valuable patents (Czarnitzki et al., 2011). More mobile researchers are found to have better   6 
access to resources and networks (Cañibano, Otamendi and Andujar, 2008) and consequently 
have a higher innovative performance (Hoisl, 2007; Palomeras, 2010).   Improved innovation 
performance is also found for the firms hosting mobile researchers (Song, Almeida and Wu, 
2003;  Rosenkopf  and  Almeida,  2003;  Singh,  2008),  and  even  for  the  firms  losing  their 
inventors (Corredoira and Rosenkopf, 2010; Oettl and Agrawal, 2008).  As a result, mobility 
across firm boundaries relates to more effective transfer of knowledge (Singh and Agrawal, 
2011). 
While  the  existing  firm  level  empirical  analyses typically  find  a  positive  relation 
between science-driven basic research activities of the firm and innovation outcomes, these 
analyses pay little attention to the actual micro-level mechanisms that link science-driven 
basic  research  activity  to  innovation  performance.  At  the  same  time  the  invention  and 
inventor level analyses do not control for organization level connections of the firms.  They 
limit  themselves  to  inventor  networks  without  superimposing  the  different  organizational 
structures in which these inventions are embedded, that will affect the incentives of these 
inventors  to  develop,  communicate  and  appropriate  returns  to  these  science-driven  basic 
research activities (Breschi and Catalini, 2010).  
Based  on  the  literature,  we  argue  that  the  spanning  of  organizational  boundaries 
should be more effective to access science-driven basic knowledge advances and translate this 
into  these  technological  advances.  Through  the  crossing  of  organizational  boundaries  by 
inventors  within  the  right  organizational  setting  the  frictions  in  this  knowledge  transfer 
process can be minimized. Especially, because of the tacitness and complexity of know-how 
underlying leading edge research, researcher involvement and mobility should play a pivotal 
role  within  any  cooperative  agreement  across  different  institutions.  We  will  distinguish 
between these pure boundary crossing inventor links relative to more structured organization 
level  partner  links.  More  importantly,  we  will  examine  the  interaction  between  firm  and 
inventor  level  boundary  spanning  mechanisms,  looking  for  any  possible  complementarity 
between both types of links at the invention level. While both partner and inventor links might 
be  considered  important  to  access  science-driven  basic  research,  the  complementarity 
between  them  might  be  fundamental  in  capturing  returns  to  tapping  into  basic  research. 
Organizational  level  commitments  provide  the  right  incentives  for  researchers  actively 
moving in and out of basic research to transfer their knowledge and develop it into applied 
technologies.  
Our paper most closely relates to the study of Ziedonis and Ziedonis (2005) on how 
Sematech, a research consortium specialized in semiconductor manufacturing, mediates as 
performer  and  broker  of  R&D  for  its  member  firms.  The  authors  find  that  technologies 
developed by the consortium or one of its partners are more valuable, particularly for its 
members who build on these patents more extensively and more rapidly compared to non-  7 
members. This is particularly the case for patents developed by the consortium itself. Given 
the particular features of our research setting we are able to better identify technologies that 
are  extracted  from  IMEC  by  partner  firms  and  delve  deeper  into  the  boundary  crossing 
inventor links and their effects on these technologies as we discuss in more detail below. 
2.2   How to benefit from bridging the Gap? 
Any explanation for why firms tap into science-driven basic research knowledge needs to 
argue that ultimately basic research enhances firms’ performance (Nelson; 1959; Evenson and 
Kislev,  1976;  Cassiman,  Perez-Castrillo  and  Veugelers,  2002).  Unfortunately,  we  still 
understand little about the actual process of how firms incorporate and benefit from basic 
research knowledge.  
Basic research can enhance innovative performance by increasing the average quality 
of the technologies produced. Basic research serves as a map for technological landscapes 
guiding applied research in the direction of most promising technological venues avoiding 
thereby  wasteful  experimentation  (Fleming  and  Sorenson,  2004).  A  better  and  more 
fundamental  understanding  of  the  technology  landscape  encourages  non-local  search  for 
improving technologies as opposed to local search, leading to more diverse research projects 
being explored with higher potential pay-offs.  
Firms will need to develop the technologies based on science-driven basic research 
into more applied technologies ready for commercialization. Probably the most discussed 
argument  of  how  actively  engaging  in  basic  research  might  increase  applied  research 
productivity is the fact that basic knowledge leads to a better identification, absorption and 
integration of external (public) knowledge (Cohen and Levinthal, 1989; Gambardella, 1995; 
Cassiman and Veugelers, 2006). Faster identification, absorption and integration of external 
knowledge in turn leads to increased productivity of the applied research process, resulting 
into new technologies (Fabrizio, 2009; Cassiman et al., 2008).  This process of integration 
requires  firms  to  develop  the  initially  acquired  technologies  even  further  into  applied 
technologies and eventually into commercializable products and processes leaving a trace of 
technologies linking the basic research knowledge to actual applied technologies of the firms. 
In addition,  more basic knowledge can simultaneously fertilize different research projects 
(Cockburn  and  Henderson,  1998),  again  requiring  the  firm  to  develop  generic  insights 
gleaned  from  basic  research  into  more  applied  technologies  and  spurring  additional 
technology development within the firm.  
In summary, science-driven basic research should stimulate the quality of the applied 
technologies developed by firms.  In addition, we would expect firms to take advantage of 
basic research by building on these knowledge flows through the internal development of 
commercially  viable  technologies  and  products.  The  process  through  which  firms  benefit 
from  science-driven  basic  research  requires  firms  to  set  up  mechanisms  to  bridge  the   8 
community and institutional gaps discussed before in order to access and develop higher 
quality technologies. These technologies subsequently need to be developed further internally 
for the firm to appropriate returns to more applied, but related technologies.  
 
In this paper, we will attempt to lay bare this process of how firms can capture value 
from  linking  to  science-driven  basic  research  and  transfer  the  linked  basic  research  into 
applied technology development. By considering together the combination of different links 
and different measures of capturing value from basic research, we provide a first glimpse into 
this  process.    We  do  this  for  the  case  of  a  particular  research  organization  in  the 
microelectronics and semiconductor field.   
 
3.  Research Setting: microelectronics and IMEC  
In our analysis we focus on the micro-electronics industry and analyze the effect of links with 
IMEC – the Interuniversity Microelectronics Center – a world class research institute with a 
mission to be a bridge between science-driven basic research at universities and problem-
driven applied research in industry.  
 
3.1.  Links to basic research in the micro-electronics industry 
The micro-electronics industry is an interesting environment for testing effects of links with 
science-driven  basic  research.  First,  academic  research  is  often  at  the  forefront  of 
breakthroughs in nano-electronics, and for this reason companies are seeking to cooperate 
with universities and research institutes to tap into emerging research opportunities as early as 
possible. Academics are at the forefront of discoveries within their field, but the challenge 
remains to bridge the large gap between the application-oriented needs of the industry and the 
results from scientific research performed at universities and research institutes.  
Second, in the semiconductor business technological knowledge is mostly tacit in 
nature. Knowledge sharing via researcher interaction and mobility between firms and research 
organizations is shown to be the crucial mechanism to bridge this gap (Meyer-Krahmer and 
Schmoch,  1998).  In  addition,  patenting  is  a  standard  practice  in  this  industry  (Hall  and 
Ziedonis,  2001)  and  as  a  result,  patents  provide  a  clear  window  on  the  technology  and 
innovation activity in the industry.  
 
3.2.  IMEC as  link to science-driven basic research  
IMEC was founded in 1982 by the regional Flemish government in Belgium as a non-profit 
organization with a mission to bridge the gap between fundamental research at universities 
and R&D in the industry. The center was built on the academic reputation and prominence of 
the electrical engineering department of the University of Leuven. The center’s involvement   9 
in  the  scientific  community  is  illustrated  by  its  close  collaboration  with  world-class 
universities, by the numerous conference participations and publications from its researchers 
and by the presence of pre-doctoral researchers at its laboratories.
2   
At the same time, IMEC is closely connected to industry. The board of directors 
includes delegates from industry who stipulate the center’s strategic roadmap focused on pre-
competitive application-oriented technologies three to ten years ahead of industrial needs. 
IMEC was able to attract top industry leaders such as Intel, Samsung, Texas Instruments, 
Micron,  NXP,  Hynix,  Elpida,  Infineon,  Panasonic,  TSMC,  Sony,  Qualcomm  and  ST 
Microelectronics willing to pay the hefty fees to become a partner. With IBM in Albany, 
IMEC  in  Leuven  has  become  one  of  the  two  most  important  centers for  nano-electronic 
research with an important focus on process technologies.  
 
3.3.  IMEC’s Industrial Affiliation Program  
IMEC has developed a unique business model which stimulates the interactions of scientific 
and  industrial  researchers  in  order  to  facilitate  cross-fertilization  of  ideas.    In  IMEC’s 
Industrial Affiliation Program participating companies share costs, risks, human resources 
and intellectual property while engaging in collaborative R&D on more generic technologies. 
Each partner firm  can send  researchers to collaborate  in the  programs in  which the  firm 
participates. Guest researchers, including academic and industrial researchers affiliated to one 
of its partners, conduct research at the IMEC laboratories in close collaboration with other 
researchers.  Around  15  different  industrial  affiliation  programs  were  running  in  2010,  of 
which a large majority in the Process Technology Unit, focused at the next generation of 
semiconductors.  Besides IMEC’s own research personnel (about 1000), more than 520 guest 
researchers with 60 different nationalities were conducting research at IMEC’s laboratories in 
2010, including 344 industrial researchers.  
 
3.4.   IMEC’s IPR-model  
Crucial for its industrial affiliation program business model is an aligned Intellectual Property 
(IP)-strategy so that all collaborating partners are able to build their own and unique IP-
portfolio  on  top  of  shared  IP.    IMEC  has  elaborated  an  IP-strategy  to  stimulate  this 
technology development and to limit blocking amongst its corporate partners (Van Helleputte, 
2004).
3  The basic platform technologies are accessible to all its partners.  These technologies, 
developed by IMEC or by IMEC in collaboration with partners, are still in a precompetitive 
                                                 
2 In 2010, IMEC was collaborating with approximately 200 universities worldwide in its core CMOS 
(Complementary Metal Oxide Semiconductor) division only and hosted 194 visiting PhD students at its 
research facilities. IMEC’s own researchers, around 1000, published more than 1,750 scientific articles 
in 2009. 
3 Johan Van Helleputte is the director for strategic development at IMEC.   10 
phase and require additional R&D to be ready for final application.  Corporate partners can 
build on these technologies to develop proprietary IP in line with their own commercial needs. 
All technology developed at the IMEC laboratories, in execution of dedicated programs by 
academic  or  industrial  researchers,  is  contractually  co-owned  by  IMEC  unless  otherwise 
contractually  stated.  Partners  gain  access  to  these  technologies,  as  far  as  needed  for  the 
exploitation of the program, via a non-exclusive and non-transferable license.  Technologies 
which result from proprietary research activities within IMEC or at the company are assigned 
exclusively to the partner. These technologies should represent an important part of the return 
on the firm’s investment in IMEC. 
IMEC’s business model and the corresponding IP-model are recognized worldwide as a 
successful  medium  to  stimulate  industry-science  links,  R&D  collaboration  and  ultimately 
technology development in the industry.  For our analysis, it allows to track the mobility of 
people and ideas around IMEC, as will be detailed in the next section. 
 
4.  Data and Methodology  
4.1.  Data and Sample  
Our dataset is constructed by exploiting IMEC’s basic IP-model. First, we collected all patent 
applications filed by IMEC between 1990 and 2005 which we retrieved from the Worldwide 
Patent Statistical Database (PatStat edition April 2008). This set of patents was validated by 
IMEC.
4 From this sample of 578 IMEC patents, we identified 531 unique inventors – IMEC 
inventors
5 and we retrieved all subsequent patents in the patent database where these IMEC 
inventors are listed as an inventor.
6 From this sample of subsequent patents we then identified 
all patents from IMEC inventors where the inventor was  not on the IMEC payroll at the time 
of application for this subsequent patent and where a private company is the owner of the 
patent. We name the IMEC inventors listed on these patents boundary crossing inventors as 
they have been active as an IMEC inventor in the generation of IP at IMEC at some point in 
their career and are not an IMEC employee at the time of patenting this subsequent company 
patent  which  implies  some  mobility  event  crossing  organizational  boundaries  during  the 
                                                 
4 These patents include 281 EPO, 255 USPTO and 42 PCT patent applications 
5 Note that given the structure of the IMEC programs these IMEC inventors are not necessarily formal 
IMEC employees as IMEC hosts many different types of researchers, including IMEC employees, 
affiliate partner employees, post-docs, doctoral students and master students, academic faculty, etc… 
Inventors listed on patents have contributed to the invention, but do not necessarily have any legal right 
to the invention. 
6 All different name variants and corresponding person identification numbers of this set of inventors 
were retrieved using search keys to take into account different spellings. The match of inventor names 
was made based on matches of name, first name, initial and address. In the case of differences in 
addresses or names, we checked the technology field of the patent and the applicant name to determine 
a match. While this rigorous approach might lead to false negative matches (type I error), it 
minimizes/eliminates false positive matches (type II error). Given our objective to trace inventor 
interaction and mobility, this conservative approach seems more appropriate.   11 
IMEC inventor’s career.
 7 Finally, we also collected all subsequent patents citing the set of 
578 original patents owned by IMEC. These citing patents are posterior to the development of 
this  IMEC  technology  but  share  the  same  technological  space  as  the  IMEC  patents  and, 
therefore, provide a reasonable comparison group for our selection of patents with a boundary 
crossing inventor from IMEC.
8  
Our final sample of company patents used consists of 1,089 USPTO patents  – 221 
patents with a boundary crossing inventor and 868 citing patents – from 87 companies, of 
which 33 are IMEC partners, with 1,835 unique inventors of which 62 are boundary crossing  
inventors.
9  
Based on our sample construction we define four types of patents along two key 
dimensions: 
 
                         {   }  indicates that patent i of firm f has a boundary crossing 
inventor and                         {   }  indicates that patent i belongs to an IMEC 
partner firm, i.e. firm f is an IMEC partner.
10 
 
 The four patent types are:  
  Boundary-Crossing-Partner  patents  are  patents  assigned  to  an  IMEC  partner 
organization (i.e. a member of its industrial affiliation program) and developed by a 
boundary crossing inventor, i.e. an inventor that has been active in the generation of 
IP at IMEC at some point earlier in his career but currently not an IMEC employee:  
   
                                   
                                                 
7IMEC has a database with all researchers which have been working at IMEC for at least one month 
(own personnel as well as visitors) and their status.  The use of detailed personnel data obtained from 
IMEC for all IMEC inventors in our sample allows us to identify the affiliation of an inventor at a 
particular moment in time. Not all inventors in our sample were found in the database. For those which 
were potential boundary crossing inventors, we conducted a web search to find additional information 
on their employment. Inventors which were working for the assignee company at the time of patenting 
are treated as boundary crossing inventors while those for which we don’t find information on their 
affiliation or who weren’t working for the assignee company were excluded from further analysis. 
8 Note that the patents with a boundary crossing inventor do not necessarily cite any of the IMEC 
patents. But they have an inventor in common with at least one of these patents. In the robustness 
checks we will look at alternative comparison samples. 
9 The initial sample consists of 5,802 patents (825 IMEC patents, 1,038 patents from IMEC inventors 
and 3,939 other patents citing IMEC patents), 7,566 unique inventors and 1,348 unique applicants, 
including around 1,200 companies, 82 universities and 66 research centers. For the remainder of the 
analysis, we restrict attention to USPTO patents only (3,606) and subsequently eliminate patents 
(co)assigned to IMEC (302), patents not assigned to companies (488), patents from companies with 
less than 4 patents in our sample (502), patents which do not share the same technological space as the 
IMEC patents (65), patents assigned to boundary crossing inventors before they were at IMEC (288), 
for which we don’t have all relevant characteristics (e.g. assignee information (546) or on the affiliation 
of the IMEC visiting researcher) (326).  
10 In the robustness section we will deal with some obvious selection issues related to both partners and 
inventors.   12 
  Citing-Partner patents are patents assigned to IMEC partners citing IMEC-owned 
patents, but without being developed by a boundary crossing inventor: 
   
     (                   )             
  Boundary-Crossing-NonPartner patents are patents assigned to non-partner 
companies, but that have a boundary crossing inventor as an inventor on the patent: 
   
                         (             )  
  Citing-NonPartner patents are patents assigned to non-partner companies, citing 
IMEC patents but without being developed by a boundary crossing inventor. 
   
      (                   )   (             )  
 
The classification of the patents according to this methodology allows us to estimate the 
impact of boundary crossing inventors – a spot in the lab – and/or firm partnerships – a seat at 
the table – at the invention (patent) level.
11 The strongest link is a combination of boundary 
crossing inventors and a partner link, as is the case for  Boundary-Crossing-Partner patents. 
Patents that only have an institutional partner link with the research center are Citing-Partner 
patents, while Boundary-Crossing-NonPartner patents are patents with only an inventor link 
to IMEC. These are most likely poaching cases whereby a non-partner company hires away 
an IMEC inventor. Finally, Citing-NonPartner patents don’t have a partner nor inventor link 
except for the fact that these patents cite IMEC patents and, hence, were developed in the 
same technology space. These are the ultimate control group for comparison with our various 
patent types. Note that in contrast to some of the literature, we do not argue that a citation by 
a firm patent to IMEC technology constitutes a genuine knowledge link. We use citations 
only for identifying patents that are related in technology space and, hence, provide an even 
tighter control on the type of technologies considered.  
Table 1 below shows the classification of the types of patents according to the links 
with  IMEC and the number of observations for each type.  
Insert Table 1 here 
 
4.2  Empirical Model  
By classifying all patents according to boundary crossing inventor and/or partnership links 
with IMEC, using the Citing-NonPartner patents as the base case, we can estimate the impact 
of  different  links  and  their  interactions.    As  the  earlier  discussion  suggests,  we  consider 
different  outcomes  as  measures  of the  effects  of these inventor  and/or partner  links  with 
                                                 
11 Note that these Citing Patents necessarily are developed after the background technology of IMEC 
has been developed. Similarly, patents with boundary crossing inventors have been developed after the 
inventor passed through IMEC.   13 
IMEC. The basic empirical model and the hypotheses tests have a similar structure across the 
various outcomes considered, as described below. 
 
Let     be our dependent variable which measures a key characteristic of patent i of firm f. 
We estimate a regression of the following form:
12 
                             ∑      
 
  {               }
                
Where 
                              
                               
                                   
                       
 
The               {               }   are  our  key  parameters  of  interest  in  these 
regressions. Earlier work has found that either partner links or boundary crossing inventor 
links affect     . Our more refined empirical predictions on the effects of mechanisms for 
bridging the gap between science-driven basic research and problem-driven applied research 
discussed earlier can be translated in the following tests. 
 
Link Test: 
  A Boundary Crossing Inventor link matters; both for partner and non-partner firm 
patents: 
                                       
  A Partner link matters both for boundary crossing inventor patents and non-boundary 
crossing patents: 
                                       
 
We did argue that boundary crossing inventors and partner links are complementary: 
 
Complementarity Test: Complementarity exists between Partner and Inventor Links when: 
 
                               
 
                                                 
12 By “” we indicate that we are not necessarily estimating a linear equation as we describe below.   14 
4.3 Dependent Variables 
In our study of the effects of boundary crossing inventors and partner links we consider two 
types of effects on the innovation process of the firm: quality of innovations being developed 
subsequently to the linking activity and the internal translation and further development effort. 
 
4.3.1 Quality of Innovation 
To  evaluate  the  effect  of  linking  to  science-driven  basic  research  through  IMEC  on  the 
technological  impact  and  the  economic  value  of  an  organization’s  patents,  we  employ  a 
commonly used indicator in past studies to measure patent quality. The most used indicator of 
patent  value  and  quality  is  the  number  of  forward  citations  received  from  subsequent 
inventions. The number of forward citations a patent receives is related to its technological 
importance (Albert et al., 1991; Carpenter et al, 1993; Henderson et al., 1998; Jaffe et al., 
2000), social value (Trajtenberg, 1990), private value (Harhoff et al, 1999; Hall et al., 2005), 
patent renewal (Harhoff et al, 1999) and patent opposition (Lanjouw and Schankerman, 1999). 
Research based on an inventor-targeted survey to estimate the economic value of European 
patents also reveals that although forward citations carry a lot of noise, it proxies closely the 
estimated economic value (Gambardella et al., 2008). We calculate the total of all forward 
citations received by an individual patent since the year of application. We also use a fixed 
citation window of 3 years.  
We  expect  a  positive  correlation  between  boundary  spanning  links  and  forward 
citations, i.e. Boundary-Crossing and/or Partner patents are expected to have a higher rate of 
forward citations as compared to the base case of Citing-NonPartner patents.  Furthermore, 
comparing Boundary-Crossing-Partner patents with Citing-Partner patents would test for the 
additional  effect  of  a  boundary  crossing  inventor  link  for  partner  firms  (LT1.1)  while 
comparing  Boundary-Crossing-NonPartner  patents  with  Citing-NonPartner  patents  would 
test for this effect for non-partners (LT1.2).  Comparing Boundary-Crossing-Partner with 
Boundary-Crossing-NonPartner patents would test for the additional effect of an institutional 
partner  link  for  firms  using  a  boundary  crossing  inventor  link  (LT2.1)  while  comparing 
Citing-Partner patents with Citing-NonPartner patents would test for this link for firms using 
a boundary crossing inventor link (LT2.2).  
If inventor and organizational links are fully complementary, i.e. boundary crossing inventor 
links are more effective for partners and/or partners get more value out of boundary crossing 
inventors, we have that the marginal effect of a crossing inventor on a partner patent is larger 
than the marginal effect of such an inventor for non-partners (CT). 
  To estimate the technological impact of the patents as measured by their number of 
forward citations, we use count models as the dependent variable is a non-negative integer. 
The specification of our baseline model as a Poisson or a Negative binomial model follows   15 
previous studies. We first estimate the Poisson quasi-maximum likelihood model (PQML) 
because  this  renders  consistent  estimates  given  that  the  mean  is  correctly  specified 
(Gouriéroux  et  al.,  1984).  We  also  use  a  Negative  Binomial  model  which  allows  for 
overdispersion  and  heterogeneity  across  observations.  Moreover,  our  sample  has  a  large 
number of observations with zero value (31% of 1,089 patents). To deal with this issue, Zero-
Inflated Poisson (ZIP) and Negative Binomial models (ZINB) are estimated (Long, 1997). 
  
4.3.2  Internal Development Effort 
Firms working in a particular technology area can build on their internal knowledge. Self-
citations reflect this capacity of the firm to build further on its existing internal technologies 
(Hall,  Jaffe,  &  Trajtenberg,  2001,  2005;  Jaffe  &  Trajtenberg  2002).  We  calculate  the 
proportion of forward citations of our sample patents that are self-citations as an indicator for 
the extent to which  linking firms succeed to build forward on these technologies . Hence, the 
proportion of self-citations reflects the extent to which the company is able to, or attempts to, 
appropriate the returns to its linking efforts.
13   
  We expect firms with links to IMEC to have a higher capacity and incentive to build 
further on IMEC related  internal knowledge. In particular, comparing Boundary-Crossing-
Partner  patents  with  Boundary-Crossing-NonPartner  patents  (LT2.1)  and  Citing-Partner 
patents and Citing-NonPartner patents (LT2.2) tests for the importance of a partner link with 
IMEC. Furthermore, comparing Boundary Crossing-Partners with Citing-Partners (LT1.1), 
tests for the additional effect of an inventor link next to an institutional link. These inventor 
and organizational links are complementary when boundary crossing inventor links are more 
effective for partners and/or partners can translate better with boundary crossing inventor 
links (CT). 
To estimate the importance of building further internally on IMEC related technology 
we regress the proportion of self-citations of the patent on our control variables and patent 
indicators for the type of link with IMEC, while controlling for the total number of forward 
citations received. We use OLS,heteroskedastic Tobit and fractional logit models (Papke and 
Wooldridge, 1996) . 
 
4.4  Control Variables  
To obtain consistent estimates, we include control variables at the patent level and firm level. 
At the patent level, we first control for 30 patent technology classes as defined by Fraunhofer 
(FhG-ISI, Germany) based on concordance with IPC codes (OECD, 1994). As pointed out by 
                                                 
13 See also Alcacer and Zhao (forthcoming) where they argue that the regional dispersion of inventors 
on self-citations allows firms to appropriate returns from inventions in different regions depending on 
the competitive environment of the region of the focal invention.   16 
Fabrizio (2009), patents in fast evolving technological classes will cite more recent patents on 
average so that we need to control for this bias. Also, as illustrated by Hall and Ziedonis 
(2001),  citation  lags  in  computers,  communications  and  electronics  are  relatively  short 
compared  to  other  technological  fields.  Moreover,  different  technological  classes  are 
characterized by different citation patterns, both in the amount and the scope of citations to 
patents and scientific literature. Traditional technological fields typically cite more and are 
cited less, whereas emerging technological fields are cited more but are average in terms of 
citations made.  
Second, we control for changes in citation patterns over time and for truncation by 
including application year dummies. In addition, we introduce patent scope as the number of 
core International Patent Classification (IPC) codes listed on the patent. Patent scope could 
determine the extent of patent protection and monopoly power and thus the economic value of 
an invention (Scotchmer, 1991). At the same time, more IPC classes covered by the patent 
could also affect the likelihood of being cited as the patent covers more technology space. 
The count of citations to scientific work (NPRS) is included as an additional control as more 
references to scientific work are associated with a higher number of received citations merely 
because the act of publication allows the ideas underlying the patent to diffuse more broadly 
and rapidly (Fleming and Sorenson, 2004) or because of possible higher economic value of 
these patents (Harhoff et al., 2003). Similarly, we control for the number of backward patent 
references to control for unobserved factors affecting citation behavior. 
We include the number of inventors as an additional control because more inventors 
might lead to a faster and greater diffusion of the tacit and complex knowledge underlying the 
patent, resulting in different forward citation patterns. This measure is also used to control for 
the resources invested in developing the technology. 
We include for each patent inventor his experience to control for a potential inventor 
selection issue. Particular types of technologies might be developed by more competent or 
experienced researchers. We calculate inventor experience as the number of patents filed at 
the USPTO by the inventors of the focal patent before the application year. We made use of 
“the careers and co-authorship networks of U.S. patent-holders” data (Lai, D’Amour and 
Fleming, 2009) to identify inventor histories. 
Next, we introduce for each patent additional measures on the organization of R&D 
at the firm level to control for firm specific variation at the time of patent application.
14 
Several arguments have been advanced as to why organization size matters for research 
productivity.  First,  larger  organizations  wield  more  resources  and  are  able  to  exploit 
economies of scale in research (Cassiman et al., 2005). Cassiman, Perez -Castrillo  and 
                                                 
14 These firm-level variables vary across different patents of the same company applied for at different 
moments in time. They are calculated at the company application year level.   17 
Veugelers (2002) find that larger firms have an incentive to proportionally invest more in 
basic research as it increases the productivity of applied R&D. Second, larger organizational 
size allows more specialization. In larger firms, researchers work on more projects but are 
more specialized in the type of projects they engage in (Kim et al., 2004). Third, larger 
companies are able to exploit economies of scope. As larger firms are active in different 
product markets and technology domains, more opportunities for exploiting economies of 
scope within the firm arise (Cassiman et al., 2005; Henderson and Cockburn, 1996).  Scale is 
calculated as the number of US patents filed by the firm in the 5 years before the application 
year of the patent and Scope as the number of distinct IPC codes of a company’s patents in 
the 5 years before the application year of the patent. Finally, Age Company is included as the 
number of years since the company’s first patent at the moment of the filing of the focal 
patent.  Sorenson and Stuart (2000) find that on the one hand older firms produce more 
patents, but on the other hand these same firms produce less valuable patents. Moreover, older 
firms self-cite more and have older backward citations.
15   
 
5  Results  
5.1  Descriptive analysis  
Table  2  presents  some  descriptive  statistics  for  the  total  sample,  while Table  3  gives  an 
overview of descriptive statistics by patent type. The IMEC-owned patents are more likely to 
cite the scientific literature (non-patent reference binary), confirming the more science-driven 
basic  nature  of  these  patents.  But  at  the  same  time  our  selection  of  patents  from  IMEC 
partners  and  non-partner  firms  are  significantly  more  likely  to  cite  scientific  literature 
compared to an average US patent which is about 30%. 
Insert TABLE 2&3 here 
When we look at the partner and non-partner patents, we see that Boundary-Crossing-
Partner patents, which have both a boundary crossing inventor and an institutional partner 
link to IMEC, receive the highest number of forward citations. This is particularly clear when 
we  restrict  the  citation  window  to  3  years,  controlling  for  the  exposure  time  of  patents.  
Citing-Partner  patents  with  only  an  institutional  partner  link  to  IMEC,  but  without  the 
boundary  crossing  inventor  link,  are  as  likely  as  Boundary-Crossing-Partner  patents  to 
receive forward citations, but the count of these citations is lower.
16  
                                                 
15 Note that their interpretation of self-citations does not correspond to our notion of appropriation in 
science intensive businesses. See also Catani (2005) for a similar interpretation of self citations in 
optical fiber technology. 
16 Ttest on difference of means Boundary-Crossing-Partner vs Citing-Partner: count forward citations 
within 3 year: t=3.83***;    18 
Both Boundary-Crossing-Partner and Citing-Partner patents are more likely to be 
built upon internally as the partner is more likely to continue developing technology in that 
area. Self-citations to these patents are much higher.
17   
  In summary, these first descriptive results already indicate that the tighter the link 
with IMEC, the more able a company seems to assimilate the knowledge captured by the 
invention  and  to  use  this  knowledge  to  develop  subsequent  inventions.  We  argued  that 
because  of  the  tacitness  and  complexity  of  know  how  underlying  leading  edge  research, 
researcher  interaction  and  mobility  does  play  an  essential  role.  We  indeed  observe  that 
individual inventors visiting the research center in order to collaborate with other industrial 
and scientific researchers in joint R&D projects – i.e. boundary crossing inventors – seem to 
play a decisive role as link between industry and IMEC, but most importantly when they are 
associated with firms that have an institutional partnership link with IMEC. These descriptive 
statistics, although not controlling for other factors, are already supportive for the positive 
impact of IMEC links for firms’ technology development, particularly the combined inventor 
and partner link. Maybe more surprising given all the literature on inventor networks and 
mobility is the finding that a boundary crossing inventor when he is operating outside an 
institutional partner link (Boundary-Crossing-NonPartner patent) does not seem to result in 
higher quality technologies being captured and developed by the non-partner firm. 
 
5.2  Quality of Innovation 
Table 4 shows the results of our count model estimations: Poisson (1,2), Negative Binomial 
(3) and Zero-inflated Negative Binomial (4). Regressions (5) and (6) where we estimate a 
(Zero-inflated)  Poisson  Count  model  and  use  the  forward  citations  received  in  a  3-year 
window as the dependent variable are probably the most stringent specifications. Boundary-
Crossing-Partner  patents  receive  between  46%  and  94%  more  citations  compared  to  the 
control group of Citing-NonPartner patents depending on the model selected.   For firms that 
are not IMEC partners, patents developed with the assistance of boundary crossing inventors, 
are not more valuable compared to patents developed without the assistance from boundary 
crossing  inventors.    Our  expectation  that  boundary  crossing  inventors  are  a  pivotal 
mechanism for linking therefore only seems to hold for firms that also have an institutional 
link.  This is confirmed by the significance of the LT2.1 test in regressions (5) and (6), which 
states that a boundary crossing inventor will have a higher effect for partnering than for non-
partnering  firms.    These  results  are  supportive  for  complementarity  between  partner  and 
boundary crossing inventor links.  The formal test for complementarity is only significant at 7% 
for the fixed citation window results (regression (5)).  
                                                 
17 Ttest on difference of means Boundary-Crossing-Partner vs Boundary Crossing-
NonPartners:t=2.98***; Citing-Partner vs Citing-NonPartners:t=3.23***   19 
Insert TABLE 4 here 
As expected, the scope of the patent (Count IPC) and the number of scientific publications 
cited  by  the  patent  (NPRs)  are  positively  related  with  the  number  of  forward  citations 
received, while the age of the company is negatively related. Scale of the firm is positive and 
Scope of the firm is negative, but these coefficients are not estimated precisely across all 
regressions.  
 
5.3  Internal Development Effort 
Building further on technology linked to IMEC technologies is an important way to 
capitalize and appropriate returns from linking to science-driven basic research. As expected, 
IMEC partners are more likely to build further on these technologies, as indicated by the 
higher proportion of self-citations received by both Boundary-Crossing-Partner and Citing-
Partner patents (See Table 5). This result is in line with Ziedonis and Ziedonis (2005), which 
find that member firms of the SEMATECH consortium are building upon the results of their 
collective research to a greater degree than are non-member firms. These patents are expected 
to have on average a 6% to 10% larger proportion of self-citations relative to comparable 
patents  by  non-partners.  Although  we  find  that  partner  patents  with  a  boundary  crossing 
inventor link have a larger proportion of self-citations compared to patents of partners without 
a boundary crossing inventor link, this difference is not statistically significant (LT1.1). There 
is, hence, no evidence of significantly higher effects from the inventor link for partnering 
firms with respect to the proportions of self-citations.A patent from a non-partnering firm but 
with a boundary spanning inventor link actually has a significantly smaller proportion of self-
citations compared to patents from boundary spanning inventors at partner firms (LT2.1). 
This  result  seems  to  suggest  that  if  there  is  no  institutional  link  with  IMEC  the  hiring 
company  is  not  able  to  fully  appropriate  the  return  to  its  investments  relative  to  others 
building forward on the technologies developed by this researcher. Being able to fully exploit 
the researcher mobility link seems to require a complementary institutional link. 
All these findings are supportive of the complementary role of boundary spanning 
inventors  and  institutional  partnerships  in  order  to  better  absorb  the  complex  and  tacit 
technological  knowledge  underlying  micro-electronics  research  through  the  internal 
development of the next generation of technologies.  The test for complementarity is indeed 
statistically significant at the 1% level for the Tobit regressions that control for censoring of 
our dependent variable. 
Insert TABLE5 here 
The count for forward citations is highly significant and positive as a control. Scope of the 
firms is negatively related to the proportion of self-citations. Together with the negative effect   20 
of scope on the number of forward citations received this might indicate a loss of focus for the 
firms with broader scope. The number of backward patent citations (PRS) is positively related 
to  the  proportion  of  self-citations.  Our  results  are  consistent  across  OLS  and  Tobit 
specifications. 
 
5.4  Robustness & Selection   
5.4.1  Robustness 
Our measure for the quality of patents is the number of forward citations while our measure 
of  internal  development  effort  is  the  proportion  of  these  forward  citations  that  are  self-
citations. One potential concern is that our quality measure is actually driven by the number 
of  self-citations  rather  than  by  the  total  citations  received  by  the  patent.  In  Table  4,  in 
regressions (7) and (8) we re-estimated our specification for forward citations without self-
citations in a 3-year window and for total self-citations as a Zero-Inflated Poisson estimation 
(ZIP). As it turns out, our results for the forward citations are sensitive to the zero-inflated 
specification because of the many “0” observations (44% compared to 31% for the overall 
sample).  We  do  find  some  interesting  differences  comparing  regressions  (7)  and  (8). 
Consistent with our findings on the proportion of self-citations in total forward citations both 
Boundary-Crossing-Partner patents and Citing-Partner patents have a significantly higher 
number  of  self-citations  compared  to  Citing-NonPartner  patents  and  Boundary-Crossing-
NonPartner patents have significantly fewer self-citations. When only taking into account 
citations coming from other firms (regression (7)), we only find that Boundary-Crossing-
Partner patents have a significantly higher number of forward citations in this specification.   
These results allows us to better interpret the results on the proportion of self-cites.   For 
Boundary-Crossing Partner patents,  the strong positive effect on self-cites rates results from a 
combination of positive effects on self-cites and external cites,  but where the latter is weaker 
than the former.   For Citing Partner patents the positive effect on self-cite rates is due a 
positive effect on number of self-cites,  while external cites are not significantly affected.   
For Boundary-Crossing-Non-Partner patents,  the negative effect on self-cite rates is from a 
negative effect on self-cites,  while external cites are not significantly affected to be able to 
compensate.    These  findings  are  consistent  with  our  interpretation  of  the  results  that  a 
combination of boundary crossing inventors and institutional partnership link is important  to 
develop high quality inventions based on their IMEC relation while firms with an institutional 
partnership link  invest more effort in internally developing IMEC related technologies. 
 
5.4.2   Sample Selection 
Our results on the positive effect of boundary crossing inventor links and partner links on the 
quality of inventions and the self-citations might be sensitive to the control sample of patents   21 
selected. As mentioned, we construct our control sample for the sample of boundary crossing 
patents based on patents that cite a set of IMEC-owned patents. We argued that this helped to 
construct a sample of patents in the relevant technology field for IMEC related technologies. 
Nevertheless, we check the robustness of our findings by selecting a more generic and a more 
restrictive  sample  of  patents.  First,  we  follow  standard  procedure  to  construct  a  control 
sample of patents assigned to a non-partner company sharing the same technology class (IPC4) 
as the focal patents with a boundary crossing inventor. Among the group of matching patents 
based on technology class, we select for each patent in our sample a control patent with the 
closest  application  date.  Second,  as  a  more  restrictive  control  group  we  select  a  similar 
control sample of patents with the additional requirement that the patent is assigned to the 
same  company  to  create  a  stricter  control  on  the  boundary  crossing  characteristic  of  the 
inventor listed on the focal patent. Finally, we restrict our actual sample to patents that only 
cite IMEC-owned patents, i.e. we also restrict the patents with a boundary crossing inventor 
to patents that also cite IMEC-owned technology. Table 6 presents the descriptive statistics 
for the different samples together with our original descriptive results. Our results remain 
valid, but the small sample size precludes us from obtaining significant results for all samples. 
Insert TABLE 6 here 
Interestingly, the control groups based on IPC code, and IPC code and firm find an average 3-
year citation count (2.10; 2.83) and self-citation proportion (0.14; 0.15) for partner patents 
that is comparable to or lower than is the case for our control groups of citing patents with 
2.38 for the average of 3-year forward citations and 0.20 for the proportion of self-citations. 
This reassures us that our control group based on citing patents is more restrictive. When 
restricting  the  sample  to  all  patents  that  cite  IMEC-owned  technology,  our  results  on 
boundary crossing inventor patents also holds up with an average 3-year forward citation 
count of 4.25 compared to 4.42 in the case of a partner patent and 1.44 compared to 1.69 for a 
non-partner patent. But one should note the low number of observations for the boundary 
crossing inventor patents that also cite the original IMEC technologies which is somewhat 
surprising. 
 
5.4.3   Partner and Inventor Selection 
While  the  empirical  results  are  supportive  for  the  tangible  effects  of  links  with  IMEC, 
particularly for the combination of inventor and organizational spanning mechanisms, we 
need to address potential selection issues at the level of the partner firm and the inventor.  
A  first important concern  is that  the  positive  effect  of  the  partner  link  on  patent 
quality and in particular on self-citations might be driven by elements that favor a company 
being a partner rather than the effect of the partner link per se. In an attempt to more formally   22 
control for this partner selection issue, we estimated the probability of a particular patent to be 
from an IMEC partner at a particular moment in time in function of patent characteristics, the 
company’s core technological area,
18 the location of its headquarters (USA/Europe/Japan), 
whether the firm is in the top 25 of largest semiconductor firms as well as its scale, scope and 
age as defined before. The selection model (see Appendix) results in a pseudo R
2 of 0.45 and 
we make 82% correct predictions.
19 Consequently, we calculate the propensity scores to be a 
partner patent and use kernel matching to compare  different matches of patents to examine 
the robustness of our findings. Results are presented in Table 7. 
Insert TABLE 7 here 
The matched patents basically reveal a similar story as  our regressions. Compared to the 
benchmark  case  of  Citing-NonPartner  patents,  the  superior  performance  of  Boundary-
Crossing-Partner patents is confirmed: boundary crossing inventors of partners matter for the 
quality of the technologies developed as shown for the forward citations. The effect of a 
partner link, i.e. comparing  Citing-Partner patents to Citing-NonPartner  patents, shows a 
significant  positive  effects  on  self-cites  only,  effectively  testing  LT2.2  for  this  outcome 
measure. The results from comparing Boundary-Crossing-Partners to Boundary-Crossing-
NonPartners, i.e. the additional effect of partnership for inventor links, i.e. testing LT2.1, 
confirms a significantly higher effect from Boundary-Crossing-Partner patents on average 
quality  as  well  as  on  self-citations.  These  results  thus  confirm  the  importance  of  an 
institutional link to exploit the advantages of an inventor link, even when more carefully 
matching a partner patent with a non-partner patent through our matching procedure. 
A second important concern beyond the partner selection issue is that there might also 
be an inventor selection issue in case firms would send their more competent researchers to 
IMEC resulting in the higher perceived quality of boundary crossing partner patents. From 
interviews with managers from IMEC we learned that this is not necessarily the case because 
companies do not want to share their most valuable human resources with other firms – 
including competitors – while at the same time making sure that the participating researchers 
are able of identifying, absorbing and integrating the relevant knowledge. IMEC does attempt 
to  control  such  behavior  by  providing  partners  with  regular  evaluations  of  the  boundary 
crossing researchers in the IMEC teams. We attempt to check the inventor selection issue by 
matching the prior patents of IMEC-visiting researchers, i.e. prior to these visits, with a group 
of comparable patents applied for by the same firm within the same year. Results obtained 
                                                 
18 Electrical machinery and apparatus, electrical energy; audio-visual technology; telecommunications; 
information technology; Semiconductors; optics; analysis, measurement, control technology; chemical 
engineering 
19The constant only model would correctly assign 56% of the patents.   23 
from T-tests indicate that the paired group of patents do not differ significantly,
20 suggesting 
that there is no obvious inventor selection issue.
21 
 
6  Discussion and Conclusion 
In  conclusion,  we  find  strong  support  for  IMEC  partners  to  develop  higher  quality 
innovations in the technology domain where IMEC is active. Furthermore, partner firms are 
more likely to build on these technologies internally, improving appropriation of the returns 
to R&D. Overall, we therefore conclude that institutionally linking to IMEC has provided 
some tangible benefits for IMEC partners. 
We have found that the boundary crossing inventor link, i.e. researchers of a partner 
actively engaged in joint research with IMEC are an important link in this chain as they allow 
the partner to develop higher quality innovations but in particular as they allow to capitalize 
on the returns from linking to science-driven basic research through internal development of 
the next generation of commercial technologies. The technologies developed by the bridging 
researchers are extensively used internally as a platform for further technology development.  
As these effects from boundary crossing inventor links are significantly stronger for 
IMEC partners, this suggests that companies should have a complementary institutional link 
to  benefit  from  cross-institutional  employee  interaction  and  mobility,  in  particular  for 
establishing cumulative technology development.  Hence, boundary crossing inventor links 
do not tell the whole story.  Firms need to buy a seat at the table before a spot in the lab can 
have any effect. 
   The  results  are  highly  supportive  of  the  paper’s  research  strategy  to  differentiate 
among the linking mechanisms – boundary crossing inventors and partnerships – as well as 
the impact measures – forward citations and proportion of self-citations – considered. At the 
same time they also suggest important avenues for further research. First, the analysis should 
extend the set of linking mechanisms (e.g. co-publications).   Secondly, more information on 
how firms organize internally for effective linking from case studies at partnering and non-
partnering firms would be helpful to further fine tune the search for institutional controls on 
the  effects  and  the partner  selection  analysis.  Particularly  critical  company  characteristics 
beyond the scale and scope of R&D and the age of a company need to be factored into 
explain appropriation success.   Thirdly, in order to better understand what makes the IMEC 
model  so  successful,  a  more  in-depth  study  of  IMEC  is  in  order.  As  IMEC  is  not 
characterized  by  major  regime  shifts  over  time  which  would  allow  pin-pointing  critical 
                                                 
20 We found no statistically significant differences between the number of citations received within 
three years, the proportion of self-citations, the number of IPC codes, the number of backward patent 
citations, the number of non-patent references and the number of inventors. 
21 In the case that partners are likely to send less competent researchers, this would actually bias the 
results against us.   24 
characteristics  for  success,  comparing  with  other  research  consortia  formula  is  a  more 
promising avenue to understand what makes IMEC special.   Sematech and MCC for instance, 
are alternatively consortia models in semiconductors which differ sufficiently in terms of IP 
model, public and private funding, collaboration model as well as in success (Cassiman, 1996; 
Ziedonis & Ziedonis (2005)) to make for a fruitful comparison analysis. 
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Table 2: Descriptive Statistics 
 
  Description Variables  Obs  Mean  Std Dv  Min  Max 
Count forward citations  The number of times a patent is cited as 
prior art by subsequent patents  1089  5.31  11.01  0  131 
Count forward citations within 3 years  The number of times a patent is cited as 
prior  art  by  subsequent  patents  within 
three years after publication 
1089  2.87  5.17  0  61 
Forward citations binary  Dummy  indicating  whether  a  patent 
received  citation(s)  1089  0.69  0.46  0  1 
Breakthrough Invention binary  Dummy  indicating  whether  the  patent  
receives more forward citations than the 
mean+2*StDev of the number of forward 
citations  in  the  same  technology  class 
application year group 
1089  0.05  0.22  0  1 
Count forward self citations  The number of times a patent is cited by 
patents assigned to the same company  1089  1.31  5.49  0  116 
Count forward self citations within 3 years  The number of times a patent is cited by 
patents of the same company within three 
years after publication 
1089  0.81  2.23  0  27 
Proportion forward self citations  The  number  of  self  citations  divided  by 
total amount of forward citations  1089  0.17  0.31  0  1 
Forward self citations binary  Dummy  indicating  whether  a  patent 
received  self citation(s)  1089  0.32  0.47  0  1 
Patent scope / Count IPCs  The number of IPC codes   1089  2.58  2.07  1  14 
Count non-patent references (NPRS)  The  number  of  ISI  web  of  knowledge 
scientific publications cited  1089  7.76  15.53  0  99 
Count patent references (PRS)  The number of patents cited by the patent  1089  30.41  31.43  0  147 
Count inventors  The number of inventors on the patent  1089  2.94  2.10  1  15 
Inventor experience / Count patents (‘000)  The  number  of  patents  (in  ‘000)  applied 
for by the inventors before the application  1089  0.07  0.15  0  2 
Scale / Count patents last 5 years (‘000)  The  number  of  patents  (in  ‘000)  the 
applicant company applied for in the last 5 
years before the application 
1089  4.25  4.39  0  20 
Scope / Count IPC’s last 5 years (‘000)  The number of unique IPC codes (in ‘000) 
appearing  on  the  company’s  patents 
applied for in the last 5 years before the 
application 
1089  1.27  1.16  0  5 
Age company  The number of years since the company’s 
first patent  1089  50.92  28.19  4  109 
 
 
TABLE 3: Descriptive Statistics (Average) by Patent Type 
 
  IMEC 
patents 
IMEC PARTNER   NOT IMEC-PARTNER 

















Count forward citations  7.38  7.32  4.40  5.80  5.48 
Count forward citations within 3 y  3.25  4.42  2.38  1.69  2.86 
Forward citations binary  0.76  0.64  0.66  0.56  0.76 
Count forward self citations  0.79  2.50  1.40  0.31  0.87 
Count forward self citations within 3 y  0.35  1.21  0.90  0.11  0.61 
Proportion forward self citations  0.13  0.20  0.20  0.06  0.13 
Forward self citations binary  0.29  0.34  0.35  0.17  0.31 
Non-Patent Reference binary  0.81  0.60  0.60  0.47  0.65 
Number of Observations  255  164  433  36  433   31 
Table 4: Count Forward Patent Citations 










FOR CIT  
WITHIN 3Y 
ZIP 
FOR CIT  
WITHIN 3Y 
ZIP 
FOR CIT EXCL SELF  
WITHIN 3Y 
ZIP 
FOR SELF CIT  
WITHIN 3Y 
  (1)  (2)  (3)  (4)  (5)  (6)  (7)  (8) 
                 
BOUNDARY CROSSING PARTNER  0.6612  0.5325*  0.3727*  0.4080*  0.4754*  0.6183***  0.5673***  0.6548*** 
  [0.504]  [0.298]  [0.226]  [0.222]  [0.281]  [0.206]  [0.192]  [0.230] 
CITING-PARTNER   -0.0622  0.0718  0.0604  0.0538  0.0512  0.1484  -0.0523  0.5335*** 
  [0.169]  [0.129]  [0.128]  [0.128]  [0.150]  [0.141]  [0.113]  [0.204] 
BOUNDARY CROSSING NON-PARTNER   0.2264  0.2861  0.0897  0.1435  -0.2385  -0.0726  0.1414  -1.4783** 
  [0.267]  [0.285]  [0.319]  [0.262]  [0.262]  [0.292]  [0.236]  [0.610] 
PATENT CHARACERISTICS                 
Count IPCs    0.1296***  0.1117***  0.0989***  0.1310***  0.0911***  0.1051***  0.0721*** 
    [0.020]  [0.028]  [0.023]  [0.017]  [0.022]  [0.019]  [0.019] 
NPRS    0.0132***  0.0151***  0.0125***  0.0113***  0.0098***  0.0085**  0.0020 
    [0.003]  [0.004]  [0.004]  [0.004]  [0.003]  [0.004]  [0.003] 
PRS    -0.0029  0.0007  0.0008  -0.0009  -0.0003  -0.0025  0.0041 
    [0.003]  [0.003]  [0.003]  [0.003]  [0.003]  [0.003]  [0.003] 
Count inventors    -0.0198  -0.0236  0.0138  0.0004  0.0144  -0.0215  0.0903*** 
    [0.023]  [0.023]  [0.023]  [0.021]  [0.022]  [0.022]  [0.027] 
Inventor experience    0.2285  0.2666  -0.0573  0.1887  -0.1800  0.1522  -0.3963 
    [0.385]  [0.407]  [0.319]  [0.361]  [0.377]  [0.293]  [1.384] 
FIRM CHARACTERISTICS                 
Scale     0.0160  0.0275*  0.0250  0.0336*  0.0408*  0.0416**  0.0864*** 
    [0.019]  [0.016]  [0.016]  [0.020]  [0.022]  [0.018]  [0.031] 
Scope    -0.0441  -0.0695  -0.1041**  -0.1414*  -0.1577**  -0.0702  -0.5752*** 
    [0.079]  [0.062]  [0.053]  [0.073]  [0.062]  [0.063]  [0.149] 
Age company    -0.0066**  -0.0060**  -0.0059**  -0.0075***  -0.0069***  -0.0064**  -0.0099** 
    [0.003]  [0.002]  [0.003]  [0.003]  [0.003]  [0.003]  [0.004] 
Constant  1.1066***  1.7725***  1.3417***  1.3746***  -13.8818  1.3903***  1.2536***  0.2531 
  [0.294]  [0.336]  [0.303]  [0.316]  [16.604]  [0.199]  [0.190]  [0.324] 
Test of joint significance                 
Technology class   Incl.  Incl.  Incl.  Incl.  Incl.  Incl.  Incl.  Incl. 
Application year  Incl.  Incl.  Incl.  Incl.  Incl.  Incl.  Incl.  Incl. 
Log LH/PLH  -5123.8528  -4605.1141  -2533.7516  -2514.81  -3017.1495  -2671.067    -2233.507  -1114.171 
Observations  1089  1089  1089  1089  1089  1089  1089  1089 
(Pseudo) R-squared  0.308  0.378  0.113  0.114  0.231  0.196  0.175  0.184 
                 
LINK TEST                 
LT1.1  2.10  2.45  1.87  2.40  2.2  4.48**  9.32***  0.29 
LT1.2  0.72  1.01  0.08  2.39  0.83  0.06  0.36  5.88** 
LT2.1  0.68  0.46  0.58  0.71  4.35**  3.96**  2.22  13.5*** 
LT2.2  0.13  0.31  0.22  1.87  0.12  1.11  0.21  6.81*** 
COMPLEMENTARITY TEST  0.82  0.22  0.33  0.38  3.24*  2.12  2.35  6.73*** 
All regressions include application year, technology dummies, Citing-NonPartner patents is control group 
Robust standard errors in brackets, clustered by firm, application year and technology class dummies are used to model the variance term in the negative binomial model 
*** p<0.01, ** p<0.05, * p<0.1 
Marginal Effects (3): Crossing-Partner 70%*; Citing-Partner 7%; Crossing-NoPartner 33%   32 
Table5: Proportion Self-citations 
 
  OLS  HETORSKEDASTIC TOBIT  FRACTIONAL LOGIT 
MODEL 
  (1) 
 
(2)  (3) 
 
(4)  (5)  (6) 
             
             
BOUNDARY CROSSING 
PARTNER 
0.0784**  0.1050***  0.2184*  0.3297***  0.6112***  0.8768*** 
  [0.031]  [0.026]  [0.118]  [0.089]  [0.208]  [0.219] 
CITING PARTNER  0.0666*  0.0680*  0.1672  0.2071*  0.5332***  0.5593*** 
  [0.039]  [0.039]  [0.125]  [0.108]  [0.157]  [0.177] 
BOUNDARY CROSSING 
NON-PARTNER 
-0.0566*  -0.0358  -0.5689***  -0.4487**  -1.0011*  -0.7882 
  [0.034]  [0.038]  [0.202]  [0.197]  [0.603]  [0.604] 
PATENT 
CHARACERISTICS 
           
Count IPCs    0.0013    0.0091    0.0050 
    [0.005]    [0.014]    [0.037] 
NPRS    0.0010    0.0033    0.0050 
    [0.001]    [0.003]    [0.004] 
PRS    0.0014**    0.0051***    0.0106*** 
    [0.001]    [0.002]    [0.003] 
Count inventors    -0.0033    0.0014    -0.0271 
    [0.005]    [0.016]    [0.036] 
Count for citations  0.0029***  0.0023***  0.0148***  0.0114***  0.0168***  0.0133** 
  [0.001]  [0.001]  [0.004]  [0.004]  [0.005]  [0.006] 
Inventor experience    -0.0197    -0.1439    -0.0723 
    [0.129]    [0.548]    [0.474] 
FIRM CHARACTERISTICS             
Scale     0.0044    0.0127    0.0457 
    [0.004]    [0.021]    [0.034] 
Scope    -0.0252*    -0.1181*    -0.2457** 
    [0.015]    [0.066]    [0.124] 
Age company    -0.0001    -0.0011    -0.0017 
    [0.000]    [0.002]    [0.003] 
Constant  -0.0019  0.0121  -0.3158*  -0.4811***  -2.6176***  -2.9718*** 
  [0.044]  [0.062]  [0.164]  [0.138]  [0.316]  [0.395] 
Test of joint significance             
Technology class   Incl.  Incl.  Incl.  Incl.  Incl.  Incl. 
Application year  Incl.  Incl.  Incl.  Incl.  Incl.  Incl. 
Censoring (at 0 or 1)      75%  75%     
Heteroskedasticity test      8.34*  18.04***     
Log PLH      -752.9022  -727.8352  -402.2509  -389.1678 
Observations  1089  1089  1089  1089  1089  1089 
(Pseudo) R-squared  0.097  0.130  0.113  0.142  0.095  0.125 
             
LINK TEST             
LT1.1  0.09  0.76  0.18  0.92  0.15  1.85 
LT1.2  2.80*  0.90  7.93***  5.19**  2.76*  1.71 
LT2.1  12.94***  13.11***  15.11***  14.30***  6.75***  7.4*** 
LT2.2  2.91*  2.98*  1.78  3.71*  11.61***  9.99*** 
COMPLEMENTARITY 
TEST 
1.75  1.67  8.31***  6.46***  2.89*  3.14* 
 
All regressions include application year and technology dummies, Citing-NonPartner patents is control group 
Robust standard errors in brackets, clustered by firm, heteroskedasticity term includes 4 scale class dummies 
*** p<0.01, ** p<0.05, * p<0.1 
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Table 6: Robustness Sample Selection 
 
 
  IMEC PARTNER   NOT IMEC-PARTNER 

































IPC & FIRM 
Count forward citations  7.32  4.92  4.40  3.61  3.93  5.80  2.44  5.48  4.15  6.80 
Count forward citations within 3 y  4.42  4.25  2.38  2.10  2.83  1.69  1.44  2.86  1.84  1.70 
Proportion forward self citations  0.20  0.36  0.20  0.14  0.15  0.06  0.00  0.13  0.08  0.16 
Number of Observations  164  12  433  176  121  36  9  433  45  20 
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Table 7: Matched Partner/Non-Partner Patents 
 
 







t  TTEST 
P>|t| 
Count forward cit 3y  4.57  1.40  4.25  0.00 
Proportion self citations  0.21  0.04  5.99  0.00 
 










Count forward cit 3y  2.47  2.49  -0.07  0.94 
Proportion self citations  0.20  0.07  6.74  0.00 
 






(NON-TREATED)  t 
TTEST 
P>|t| 
Count forward cit 3y  5.39  1.69  3.91  0.00 
Proportion self citations  0.24  0.18  1.73  0.09 
 
Averages do not necessarily match the descriptives of Table 3 as only successfully matched patents within the 
common support are used in the calculation of the averages. 
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APPENDIX: Partner Patent Selection Equation 
 
   
VARIABLES  Partner Dummy Patent 
PATENT CHARACTERISTICS   
Count IPCs   -0.0760** 
  [0.0297] 
NPRS  -0.0107* 
  [0.0064] 
PRS  0.0038 
  [0.0038] 
Count inventors  0.0511 
  [0.0329] 
FIRM CORE TECHNOLOGY     
Electrical machinery and apparatus, electrical energy  -0.9625 
  [0.9643] 
Audio-visual technology  0.7735 
  [0.8911] 
Telecommunications  -1.5170** 
  [0.6508] 
Information technology  0.5640 
  [0.6704] 
Semiconductors  1.9357*** 
  [0.5286] 
Optics  1.6428* 
  [0.8448] 
Analysis, measurement, control technology  0.7639 
  [0.8669] 
Chemical engineering  2.2081** 
  [0.9916] 
HEADQUARTERS   
US  0.7623 
  [0.7775] 
EU  3.3017*** 
  [0.9592] 
Japan  -0.4943 
  [0.8549] 
FIRM CHARACTERISTICS   
Top 25 firm in sales   1.3454** 
  [0.5343] 
Scale  -0.0989 
  [0.0915] 
Scope  0.4698 
  [0.3572] 
Age  0.0052 
  [0.0096] 
Constant  -2.8132*** 
  [0.8811] 
Observations  1089 
Pseudo R-squared  0.446 
% correctly estimated  82% 
 